Aharon Hallak

1.3k total citations
34 papers, 1.0k citations indexed

About

Aharon Hallak is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Aharon Hallak has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Epidemiology. Recurrent topics in Aharon Hallak's work include Helicobacter pylori-related gastroenterology studies (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Inflammatory Bowel Disease (5 papers). Aharon Hallak is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Inflammatory Bowel Disease (5 papers). Aharon Hallak collaborates with scholars based in Israel, United States and Sweden. Aharon Hallak's co-authors include Tuvia Gilat, Shimon Reif, Flora Lubin, Itzik Klein, M. Farbstein, Menachem Moshkowitz, Fred M. Konikoff, Nadir Arber, Zamir Halpern and Y. Peled and has published in prestigious journals such as Gastroenterology, Cancer and Oncogene.

In The Last Decade

Aharon Hallak

34 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aharon Hallak Israel 15 426 316 263 184 159 34 1.0k
Yuji Funayama Japan 18 526 1.2× 394 1.2× 310 1.2× 167 0.9× 144 0.9× 95 1.1k
Christian Scheurlen Germany 14 422 1.0× 172 0.5× 165 0.6× 154 0.8× 195 1.2× 26 729
B. Kollberg Sweden 15 397 0.9× 342 1.1× 348 1.3× 139 0.8× 93 0.6× 30 821
Richard I. Breuer United States 14 406 1.0× 340 1.1× 221 0.8× 177 1.0× 158 1.0× 24 1.1k
P. Cazzola Italy 11 236 0.6× 315 1.0× 217 0.8× 118 0.6× 51 0.3× 16 815
H J Hodgson United Kingdom 20 452 1.1× 574 1.8× 636 2.4× 165 0.9× 77 0.5× 58 1.4k
A. B. Hawthorne United Kingdom 14 440 1.0× 600 1.9× 435 1.7× 127 0.7× 121 0.8× 26 1.1k
H. J. Buhr Germany 15 313 0.7× 198 0.6× 326 1.2× 75 0.4× 82 0.5× 33 930
Miriam L. Christ United States 13 235 0.6× 185 0.6× 158 0.6× 68 0.4× 117 0.7× 19 765
Peter T. Crowe United Kingdom 14 494 1.2× 145 0.5× 406 1.5× 599 3.3× 77 0.5× 19 971

Countries citing papers authored by Aharon Hallak

Since Specialization
Citations

This map shows the geographic impact of Aharon Hallak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aharon Hallak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aharon Hallak more than expected).

Fields of papers citing papers by Aharon Hallak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aharon Hallak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aharon Hallak. The network helps show where Aharon Hallak may publish in the future.

Co-authorship network of co-authors of Aharon Hallak

This figure shows the co-authorship network connecting the top 25 collaborators of Aharon Hallak. A scholar is included among the top collaborators of Aharon Hallak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aharon Hallak. Aharon Hallak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hall, Michael J., Eliezer Liberman, Eyal Sagiv, et al.. (2009). Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. Annals of Oncology. 20(9). 1517–1521. 8 indexed citations
2.
Barkay, Olga, et al.. (2008). Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial. Surgical Endoscopy. 22(9). 1971–1976. 26 indexed citations
3.
Hallak, Aharon, Raanan Shamir, Menachem Moshkowitz, et al.. (2003). Rofecoxib Reduces Polyp Recurrence in Familial Polyposis. Digestive Diseases and Sciences. 48(10). 1998–2002. 68 indexed citations
4.
Keizman, Daniel, et al.. (2003). Diagnostic yield of routine push enteroscopy with a graded-stiffness enteroscope without overtube. Gastrointestinal Endoscopy. 57(7). 877–881. 18 indexed citations
5.
Hallak, Aharon, Shlomo Brill, Itzhak Shapira, et al.. (2001). Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus. Oncogene. 20(55). 7987–7991. 43 indexed citations
6.
Dotan, Iris, Aharon Hallak, Nadir Arber, et al.. (2001). Low-Dose Low-Molecular Weight Heparin (Enoxaparin) Is Effective as Adjuvant Treatment in Active Ulcerative Colitis: An Open Trial. Digestive Diseases and Sciences. 46(10). 2239–2244. 52 indexed citations
7.
Dotan, Iris, et al.. (2001). [Treatment of Crohn's disease with anti TNF alpha antibodies--the experience in the Tel Aviv Medical Center].. PubMed. 140(4). 289–93, 368. 12 indexed citations
8.
Reif, Shimon, Itzik Klein, Flora Lubin, et al.. (1997). Pre-illness dietary factors in inflammatory bowel disease.. Gut. 40(6). 754–760. 249 indexed citations
9.
Moshkowitz, Menachem, Fred M. Konikoff, Yael Peled, et al.. (1996). One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Alimentary Pharmacology & Therapeutics. 10(6). 1015–1019. 29 indexed citations
10.
Arber, Nadir, Aharon Hallak, Iris Dotan, et al.. (1996). Increased leukocyte adhesiveness/ aggregation in patients with inflammatory bowel disease during remission. Diseases of the Colon & Rectum. 39(6). 632–635. 8 indexed citations
11.
Arber, Nadir, Menachem Moshkowitz, Fred M. Konikoff, et al.. (1995). Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection. Digestive Diseases and Sciences. 40(11). 2431–2433. 32 indexed citations
12.
Arber, Nadir, Shlomo Berliner, Aharon Hallak, et al.. (1995). Increased leucocyte adhesiveness/aggregation is a most useful indicator of disease activity in patients with inflammatory bowel disease.. Gut. 37(1). 77–80. 26 indexed citations
13.
Arber, Nadir, Fred M. Konikoff, Menachem Moshkowitz, et al.. (1994). Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Digestive Diseases and Sciences. 39(12). 2656–2659. 77 indexed citations
14.
Santo, M, Aharon Hallak, Nadir Arber, et al.. (1994). [Antimicrobial sensitivity and treatment of Helicobacter pylori infections].. PubMed. 126(3). 126–8, 176, 175. 1 indexed citations
15.
Hallak, Aharon, Ruth Rosenberg, T Gilat, & Giora J. Sömjen. (1993). Determination of Free Polyamines in Human Bile by High-Performance Liquid Chromatography. Clinical Science. 85(4). 451–454. 9 indexed citations
16.
Goldman, Gil, Zamir Halpern, Aharon Hallak, et al.. (1992). Prostaglandin E2 in duodenal ulcer complications.. PubMed. 58(1). 49–52. 1 indexed citations
17.
Rozen, Paul, Elaine Ron, Zvi Fireman, et al.. (1987). The relative value of fecal occult blood tests and flexible sigmoidoscopy in screening for large bowel neoplasia. Cancer. 60(10). 2553–2558. 33 indexed citations
18.
Burke, Margaret, et al.. (1987). Sarcoidosis Presenting with Acute Pleurisy, Hemoptysis, Pruritus and Eosinophilia. Respiration. 51(4). 248–251. 1 indexed citations
19.
Hallak, Aharon, et al.. (1986). Sabin-Feldman dye test in ulcerative colitis and Crohn's disease. Diseases of the Colon & Rectum. 29(6). 402–404. 2 indexed citations
20.
Bar–Meir, Simon, Aharon Hallak, & M Baratz. (1983). Endoscopic Removal of a Giant Duodenal Polyp. Endoscopy. 15(1). 29–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuji Funayama Breakdown of academic impact, for papers by Christian Scheurlen Breakdown of academic impact, for papers by B. Kollberg Breakdown of academic impact, for papers by Richard I. Breuer Breakdown of academic impact, for papers by P. Cazzola Breakdown of academic impact, for papers by H J Hodgson Breakdown of academic impact, for papers by A. B. Hawthorne Breakdown of academic impact, for papers by H. J. Buhr Breakdown of academic impact, for papers by Miriam L. Christ Breakdown of academic impact, for papers by Peter T. Crowe
Rankless by CCL
2026